Volume 8 - Early Access
pbp 2026, 8 - Early Access: 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ravanshad A, Kumar Mandal S. Medicinal Plants Effective Against Monkeypox: A Concise Review Focusing on Mechanisms of Action. pbp 2026; 8
URL: http://pbp.medilam.ac.ir/article-1-316-en.html
URL: http://pbp.medilam.ac.ir/article-1-316-en.html
1- Islamic Azad University, Khorramabad Branch, Khorramabad, Iran
2- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Dr. B. C. Roy College of Pharmacy and AHS, W.B., India ,gotosudip@rediffmail.com
2- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Dr. B. C. Roy College of Pharmacy and AHS, W.B., India ,
Abstract: (442 Views)
Objective: Monkeypox (MPX) is a rare viral disease that has attracted considerable attention in recent years. In the absence of a definitive treatment, medicinal plants have been explored as complementary options for symptom management and immune enhancement. This study aims to investigate medicinal plants in India with potential antiviral effects against MPX, focusing on their active constituents and mechanisms of action.
Methods: Relevant literature was retrieved from reputable scientific databases, including PubMed, Scopus, and Google Scholar, using carefully selected keywords. Studies reporting antiviral activity of medicinal plants against MPX were reviewed and synthesized.
Results: Several medicinal plants with documented effects against MPX were identified. These include Allium sativum L., Adansonia digitata L., Azadirachta indica A. Juss, Boscia senegalensis (Pers.) Lam. ex Pior, Carica papaya L., Cissus populnea Guill. & Perr., Cucurbita maxima Duchesne, Ficus platyphylla Delile, Lawsonia inermis L., Maytenus senegalensis (Lam.) Exell, Moringa oleifera Lam., Olea europaea L., Sterculia setigera Delile, Acacia nilotica (L.) Delile, Anogeissus leiocarpus (DC.) Guill. & Perr., Balanites aegyptiaca (L.) Delile, Calotropis procera (Aiton) Dryand, Cassia singueana Delile, Citrullus lanatus (Thunb.) Matsum. & Nakai, and Diospyros mespiliformis Hochst. ex A.DC.. The active phytochemicals in these plants appear to contribute to viral load reduction and overall health improvement by inhibiting viral entry and attenuating viral activity.
Conclusion: The findings underscore the therapeutic promise of these medicinal plants as complementary interventions for MPX. Their bioactive compounds may offer valuable support in alleviating symptoms and strengthening immune defenses. Continued exploration of such plant-based resources could inform the development of adjunctive strategies for managing viral diseases more broadly.
Methods: Relevant literature was retrieved from reputable scientific databases, including PubMed, Scopus, and Google Scholar, using carefully selected keywords. Studies reporting antiviral activity of medicinal plants against MPX were reviewed and synthesized.
Results: Several medicinal plants with documented effects against MPX were identified. These include Allium sativum L., Adansonia digitata L., Azadirachta indica A. Juss, Boscia senegalensis (Pers.) Lam. ex Pior, Carica papaya L., Cissus populnea Guill. & Perr., Cucurbita maxima Duchesne, Ficus platyphylla Delile, Lawsonia inermis L., Maytenus senegalensis (Lam.) Exell, Moringa oleifera Lam., Olea europaea L., Sterculia setigera Delile, Acacia nilotica (L.) Delile, Anogeissus leiocarpus (DC.) Guill. & Perr., Balanites aegyptiaca (L.) Delile, Calotropis procera (Aiton) Dryand, Cassia singueana Delile, Citrullus lanatus (Thunb.) Matsum. & Nakai, and Diospyros mespiliformis Hochst. ex A.DC.. The active phytochemicals in these plants appear to contribute to viral load reduction and overall health improvement by inhibiting viral entry and attenuating viral activity.
Conclusion: The findings underscore the therapeutic promise of these medicinal plants as complementary interventions for MPX. Their bioactive compounds may offer valuable support in alleviating symptoms and strengthening immune defenses. Continued exploration of such plant-based resources could inform the development of adjunctive strategies for managing viral diseases more broadly.
Type of Study: Review/Systemtic review |
Subject:
Phytochemistry
Received: 2025/01/17 | Accepted: 2025/06/22 | Published: 2025/12/1
Received: 2025/01/17 | Accepted: 2025/06/22 | Published: 2025/12/1
References
1. Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, et al. Monkeypox. Lancet. 2023;401(10370):60-74.
2. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58(2):260-7.
3. Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. N Engl J Med. 2022;387(19):1783-93.
4. Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduct Target Ther. 2022;7(1):1-22.
5. Petersen E, Kantele A, Koopmans M, Asogun D, Yinka-Ogunleye A, Ihekweazu C, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am. 2019;33(4):1027.
6. Hraib M, Jouni S, Albitar MM, Alaidi S, Alshehabi Z. The outbreak of monkeypox 2022: An overview. Ann Med Surg (Lond). 2022;79:104069.
7. Ahmed SK, El-Kader RG, Abdulqadir SO, Abdullah AJ, Nahed A, Chandran D, et al. Monkeypox clinical symptoms, pathology, and advances in management and treatment options: an update. Int J Surg. 2023;109(9):2837-40.
8. Soheili M, Nasseri S, Afraie M, Khateri S, Moradi Y, Mortazavi SM, et al. Monkeypox: virology, pathophysiology, clinical characteristics, epidemiology, vaccines, diagnosis, and treatments. J Pharm Pharm Sci. 2022;25:297-322.
9. Niu L, Liang D, Ling Q, Zhang J, Li Z, Zhang D, et al. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments. Front Immunol. 2023;14:1132250.
10. Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs. 2022;82(9):957-63.
11. Khani E, Afsharirad B, Entezari‐Maleki T. Monkeypox treatment: current evidence and future perspectives. J Med Virol. 2023;95(1):e28229.
12. Cheema AY, Ogedegbe OJ, Munir M, Alugba G, Ojo TK. Monkeypox: a review of clinical features, diagnosis, and treatment. Cureus. 2022;14(7):eXXXXX.
13. Zhang X, Zhou F, Zhang P, Zou Q, Zhang Y. TCM@ MPXV: A resource for treating monkeypox patients in Traditional Chinese Medicine. Curr Bioinform. 2025;20(6):557-63.
14. Khan A, Shahab M, Nasir F, Waheed Y, Alshammari A, Mohammad A, et al. Exploring the Traditional Chinese Medicine (TCM) database chemical space to target I7L protease from monkeypox virus using molecular screening and simulation approaches. SAR QSAR Environ Res. 2023;34(9):689-708.
15. Mollaamin F. Computational methods in the drug delivery of carbon nanocarriers onto several compounds in Sarraceniaceae medicinal plant as monkeypox therapy. Computation. 2023;11(4):84.
16. Sabikhi Y, Singh A. Computational analysis of therapeutic potential of Aloe barbadensis and Allium sativum targeting A42R profilin-like protein for monkeypox virus. SSRN. 2025 Apr 30. Available from: https://ssrn.com/abstract=5237228
17. Selvaraj KV, Prabha T, Karthikeyan J, Rani CI, Vethamoni PI, Bharathi A. Harnessing nature's arsenal: A comprehensive review of phytomedicine approaches in monkeypox treatment. Ann Phytomed. 2024;13(2):23-32.
18. Maideen NM, Balasubramanian R, Muthusamy S, Dhanabalan K, Sughir AA. A review of pharmacotherapeutic potentials of black seeds (Nigella sativa) in the management of monkeypox infection. Curr Tradit Med. 2024;10(2):109-16.
19. Singh L, Arora MK, Kumar P, Rustogi S, Mishra SS, Gadewar M. Medicinal plants and herbs in viral meningitis. In: Promising Antiviral Herbal and Medicinal Plants. Boca Raton: CRC Press; 2024. p. 276-94.
20. Sharma R, Chen KT, Sharma R. Emerging evidence on monkeypox: resurgence, global burden, molecular insights, genomics and possible management. Front Cell Infect Microbiol. 2023;13:1134712.
21. Khan S, Ray I. Bioactive phytochemicals for human monkeypox outbreak. Asian J Res Infect Dis. 2025;16(2):24-43.
22. Abubakar IB, Kankara SS, Malami I, Danjuma JB, Muhammad YZ, Yahaya H, et al. Traditional medicinal plants used for treating emerging and re-emerging viral diseases in northern Nigeria. Eur J Integr Med. 2022;49:102094.
23. Yousaf MA, Basheera S, Sivanandan S. Inhibition of monkeypox virus DNA polymerase using Moringa oleifera phytochemicals: computational studies of drug-likeness, molecular docking, molecular dynamics simulation and density functional theory. Indian J Microbiol. 2024;64(3):1057-74.
24. Ndayambaje M, Munyeshyaka E, Dieumerci O, Habyarimana T, Ndishimye P, Naya A, et al. Plant-derived molecules in monkeypox management: insight and alternative therapeutic strategies. Beni-Suef Univ J Basic Appl Sci. 2025;14(1):1-7.
25. El Gendy AE, Essa AF, El-Rashedy AA, Elgamal AM, Khalaf DD, Hassan EM, et al. Antiviral potentialities of chemical characterized essential oils of Acacia nilotica bark and fruits against hepatitis A and herpes simplex viruses: in vitro, in silico, and molecular dynamics studies. Plants. 2022;11(21):2889.
26. Banik A, Ahmed SR, Shahid SB, Ahmed T, Tamanna HK, Marma H. Therapeutic promises of plant metabolites against monkeypox virus: an in silico study. Adv Virol. 2023;2023:9919776.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |